MedTrace Logo

Augmenting Urinary Reflex Activity: Study 3

NCT06597994 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2025-05-15

No results posted yet for this study

Summary

AURA-3 study (Augmenting Urinary Reflex Activity Study 3) is a single arm, short-duration (8 month) cohort follow up study of preceding interventional medical device study, AURA-2.

Conditions

Interventions

DEVICE

Amber UI system

Upgrade of Amber UI system recharge accessories and system firmware

Sponsors & Collaborators

  • Amber Therapeutics Ltd

    lead INDUSTRY

Principal Investigators

  • Stefan De Wachter, MD · University Hospital, Antwerp

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-15
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06597994 on ClinicalTrials.gov